Pharmacokinetic Study of Silybin in Healthy Chinese Subjects

被引:0
|
作者
Bai, Yan-li [1 ,2 ]
Niu, Jun-long [3 ]
Zhang, Dong-dong [3 ]
Yan, Zhi-jie [3 ]
Zhang, Yu-bin [3 ]
Jiang, Yao-jia [3 ]
机构
[1] Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang 471003, Peoples R China
[2] Henan Univ Sci & Technol, Coll Clin Med, Luoyang 471003, Peoples R China
[3] Henan Univ Sci & Technol, Coll Med, Luoyang 471003, Peoples R China
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2016年 / 35卷 / 04期
关键词
silybin; HPLC; plasma; pharmacokinetic study; FATTY LIVER-DISEASE; MILK THISTLE; HUMAN PLASMA; PHOSPHATIDYLCHOLINE; CARCINOMA; SILYMARIN; CELLS; ASSAY; LC;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, a simple, rapid and sensitive high performance liquid chromatography (HPLC) method is developed for the determination of silybin in human plasma samples using midazolam as the internal standard (IS). Sample preparation was accomplished through one-step liquid-liquid extraction with ethyl acetate, and chromatographic separation was carried out on an Agilent ZORBAX Eclipse XDB-C18 column (4.6 x 150 mm, 5 pm) at 40 degrees C. Mobile phase composed of a mixture of acetonitrile-0.1% trifluoroacetic acid-water (44:31:25) at flow rate of 0.8 mL/min. Wavelength was set at 288 mu. The chromatographic retention times of silybin and IS were 435 and 5.52 min, respectively. The lower limit of quantitation (LLOQ) was 50 ng/mL, and no interferences were detected in the chromatograms. The devised HPLC method was validated by evaluating its intra- and inter-day precisions and accuracies in a linear concentration range between 50 and 6000 ng/mL. The method was successfully applied to a pharmacokinetic study of oral silybin capsules in Chinese healthy volunteers.
引用
收藏
页码:768 / 772
页数:5
相关论文
共 50 条
  • [31] Development of a HPLC-UV assay for silybin-phosphatidylcholine complex (silybinin capsules) and its pharmacokinetic study in healthy male Chinese volunteers
    Li, Wei
    Gao, Jun
    Zhao, Hong-Zhi
    Liu, Chang-Xiao
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2006, 31 (04) : 265 - 270
  • [32] Evaluation of tofacitinib citrate bioequivalence based on pharmacokinetic parameters in healthy Chinese subjects
    Yu, Bin
    Wang, Xiaoru
    Yang, Yaru
    Lu, Chao
    Hu, Wei
    Zhang, Xueyuan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (04) : 343 - 352
  • [33] Population pharmacokinetic characteristics of sirolimus in healthy Chinese subjects and renal transplant patients
    Wang, Miao
    Duan, Bao-ling
    Yuan, Yin-jin
    Su, Xia
    Zheng, Hang
    Wang, Fu-sheng
    Sun, He
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (06) : 433 - 441
  • [34] Bioequivalence Study of Epalrestat for Healthy Chinese Subjects
    Yang, Dandan
    Wang, Xiaodan
    Duan, Yi
    Xu, Yichao
    Ruan, Zourong
    Jiang, Bo
    Lou, Honggang
    Chen, Jinliang
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (05): : 485 - 490
  • [35] Single- and Multiple-dose Pharmacokinetic, Safety and Tolerability Study of Mildronate Injection in Healthy Chinese Subjects Pharmacokinetic of Mildronate Injection
    Zhao, Z.
    Chen, J.
    Peng, W.
    Wang, X.
    Chen, Z.
    Tang, H.
    Liang, Y.
    Ma, Z.
    Chen, J.
    Chen, X.
    Zhong, G.
    Huang, M.
    DRUG RESEARCH, 2016, 66 (05) : 251 - 256
  • [36] Clinical and pharmacokinetic results of upadacitinib in Chinese healthy subjects and subjects with moderate-to-severe atopic dermatitis
    Zheng, Min
    Zhang, Chunlei
    Fang, Hong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB30 - AB30
  • [37] Pharmacokinetic and bioequivalence study of meloxicam tablets in healthy male subjects
    Gschwend, Michael H.
    Erenmemisoglu, Aydin
    Martin, Wolfgang
    Tamur, Uygur
    Kanzik, Ilker
    Hincal, A. Atilla
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (05): : 264 - 268
  • [38] Pharmacokinetic and safety profiles of mesalazine enema in healthy Chinese subjects: A single- and multiple-dose study
    Cao, Yuran
    Wang, Jingjing
    Tang, Xingyu
    Tian, Yan
    Yu, Jicheng
    Liang, Hong
    Wu, Jufang
    Chen, Yuancheng
    Cao, Guoying
    Zhang, Jing
    PLOS ONE, 2024, 19 (02):
  • [39] PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF CONVENTIONAL AND CONTROLLED RELEASE FORMULATIONS OF MOTOPROLOL IN HEALTHY CHINESE SUBJECTS
    LEE, YT
    LIAU, CS
    WONG, ECK
    CHEN, WJ
    CHEN, MF
    CHEN, CC
    CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 (04) : 529 - 533
  • [40] Pharmacokinetic properties and bioequivalence of spironolactone tablets in fasting and fed healthy Chinese male subjects
    Li, Zhi-hua
    Deng, Yang
    Cai, Hua-lin
    Guo, Zhao-hui
    Hou, Zhen-yan
    Wu, Ge
    Yan, Miao
    Zhang, Bi-kui
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (06) : 455 - 461